US Patent Issued to Biograph 55 on Dec. 30 for "Anti-CD19/anti-CD38 common light chain bispecific antibodies" (California Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,527, issued on Dec. 30, was assigned to Biograph 55 Inc. (San Francisco).

"Anti-CD19/anti-CD38 common light chain bispecific antibodies" was invented by Leonard Presta (San Francisco), Paul Tumeh (San Francisco), Nils Lonberg (Woodside, Calif.) and Omar Duramad (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-CD19 and anti-CD38 common light chain bispecific antibodies. The anti-CD-19 and anti-CD38 bispecific antibodies described herein are useful in methods for treating a cancer or a tumor."

The patent was filed on March 2, 2022, under Application No. 17/685,206.

*For further information, including images, charts ...